Drugs / Fang Le Shu
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06921395 | Feb → Sep 2025 overdue | female infertility | LG Chem | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fang Le Shu | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06921395 ↗ |
| Known as | Follitrope | “Fang Le Shu (Follitrope)” NCT06921395 ↗ |
| Modality | Protein / enzyme biologic | “Fang Le Shu (Recombinant FSH)” NCT06921395 ↗ |